FDA licenses first meningitis B vaccine
Lorenzo QuiogueThe Food and Drug Administration approved Trumenba, a vaccine against meningitis type B, for active immunization in 10- to 25-year-olds on Tuesday, according to a press release by Pfizer, the manufacturer of the vaccine. This is the first vaccine against this strand of bacterial meningitis approved in the United States.